Exploring the relationship between BI 456906 exposure and change in fasting plasma glucose, fasting serum insulin, and glycated hemoglobin (HbA1c) using population PKPD modeling

This poster dissects the direct and indirect effects of survodutide, a dual glucagon and GLP1 receptor agonist, on metabolic markers in patients with type 2 diabetes mellitus.